Evidence map›Paper›PMID 34097471›Full record

ArticleInfection and immunity2021

The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.

Souwelimatou Amadou Amani, Gillian A Lang, Jimmy D Ballard, Mark L Lang

Abstract read
In one paragraph

Article in Infection and immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. The therapeutic age of the neonatal Fc receptor.Nature reviews. Immunology · 2023
    Review
  4. Host Immune Responses toFrontiers in microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Souwelimatou Amadou AmaniDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Gillian A LangDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Jimmy D BallardDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0001-8824-9609
Mark L LangDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-5137-0576

Funding

Differential Effects of TcdB1 and TcdB2 in C. difficile diseaseR01AI119048 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BALLARD, JIMMY D. · 2015 to 2024
$3.8M
Activation of semi-invariant and diverse NKT cells with an adjuvant combinationR01AI134719 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LANG, MARK L · 2018 to 2022
$1.8M
NIAID NIH HHS R01 AI119048NIAID NIH HHS R01 AI134719
6 · The paper itself

Abstract

The pathology associated with Clostridioides difficile disease is caused in large part by TcdB, an intracellular bacterial toxin that inactivates small GTPases. Despite C. difficile causing enteric disease, antitoxin IgG is a clear correlate of protection against infection-associated pathology. Immunization with TcdB-based immunogens or passive transfer of monoclonal antibodies specific for the TcdB carboxy-terminal domain (CTD) confers protection following C. difficile infection. Whether the mechanism by which circulating IgG is delivered to the gut depends on specific receptor-mediated transport or is solely reflective of infection-induced damage to the gut remains unclear. Here, we tested the hypothesis that neonatal Fc receptor (FcRn) is required for the delivery of systemic TcdB-specific IgG to the gut and protection against C. difficile-associated pathology. FcRn-expressing mice and FcRn-deficient littermates were immunized subcutaneously with Alhydrogel adjuvant-adsorbed CTD before challenge with live C. difficile spores. FcRn was required for the delivery of systemic TcdB-specific IgG to the gut and for vaccine-induced protection against C. difficile-associated disease. The lack of FcRn expression had minimal effects on the composition of the gut microbiome and did not affect susceptibility to C. difficile infection in nonimmunized mice. In further experiments, intraperitoneal injection of immune sera in FcRn-deficient mice led to the transport of protective IgG to the gut independently of infection, confirming a reported method of bypassing the FcRn. Our results reveal an FcRn-dependent mechanism by which systemic immunization-induced IgG protects the gut during enteric C. difficile infection. These findings may be beneficial for the targeting of C. difficile-specific IgG to the gut.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntitoxinsBacterial ToxinsClostridioides difficileClostridium InfectionsDigestive SystemDisease SusceptibilityEnterotoxinsFemaleHistocompatibility Antigens Class IImmunityImmunizationImmunoglobulin GMaleAntibodies, MonoclonalAntibodies, NeutralizingAntitoxinsBacterial ToxinsEnterotoxinsFc receptor, neonatalHistocompatibility Antigens Class IImmunoglobulin GReceptors, FcadjuvantantibodiesantibodyClostridioides difficileFcRnguttotaltoxintoxins

Identifiers

PMID34097471
PMCPMC8445184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.